3 Stocks With Negative ROA: Rock Creek Pharmaceuticals Inc (RCPI), Net Element International Inc (NETE), And Synthetic Biologics Inc (SYN)

Posted by Lynn Eisler January 28, 2015 0 Comment 1089 views


New York, NY – GDP INSIDER  – 01/28/2015.

Rock Creek Pharmaceuticals Inc (NASDAQ:RCPI)’s ROA stands dangerously at -538.60%. The stock had nothing to hold it up in the last session, falling 3.63% to end the day in the red at $0.181. The dull day for the pharmaceutical company saw less than average volume shifting hands at 369,922 against the daily average of 1.08 million shares. The 52-week range of the stock is $0.17 and $0.20. RCPI’s shares opened the session at $0.19 but was down 4.44% from that opening price at the end of the session. The stock stood 39% above its 52-week low and 83.27% below its 52-week high at the end of the session.

Is Rock Creek Pharmaceuticals Inc  Going To Turn It Around Or Will It Continue To Freefall? See Where RCPI Is Going Next With A Free Trend Analysis

Net Element International Inc (NASDAQ:NETE) has a ROA of 196.70%. The stock rallied upward $3.57% to add $0.04 per share and closed at $1.16 in yesterday’s session. NETE was traded in the range of $1.11 low and $1.22 high, having opened the session at $1.11. Around 334,400 shares exchanged hands way above the average daily volume of 288,323 shares. NETE saw its market cap up to $51.1 million following the gain. The stock was up 32.77% from its 52-week low and placed it 79.68% below its 52-week high.

Net Element International Inc (NASDAQ:NETE) is one of the technology providers taking a bite from Apple Inc. (NASDAQ:AAPL)’s golden mobile payment service, Apple Pay. NETE endorsed Apple Pay and said it would enable merchants using its POS platform to accept Apple Pay in their stores.

Will Net Element International Inc Continue To Move Higher Or Are Things About To Reverse? See What Is Next For NETE With A Free Trend Analysis

Synthetic Biologics Inc (NYSEMKT:SYN)’s ROA is -163.60%. The stock traded south 0.57% to $1.73 in yesterday’s session, having opened the session at $1.74. The biotech stock traded between a $1.65 and $1.75 in yesterday’s session. The yesterday’s closing price left the stock 49.14% above its 52-week low and 52.47% below its 52-week high. Synthetic Biologics Inc (NYSEMKT:SYN) shifted 638,296 shares, against the daily average of 656,813 on day that saw its market cap falling to $126.91 million.

Will Synthetic Biologics Inc Continue To Drift Lower Or Will It Be Able To Find Support And Reverse? See What’s In Store For SYN With A Free Trend Report

About HotStockGains

HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.

Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.



About Lynn Eisler

Lynn Eisler is a national news reporter focusing on economic issues, data analysis and the financial health of state and local governments. Lynn has been honored with the H.L. Mencken Award for Investigative Reporting, the Champion of Justice Award for reporting on the drug war, and the John Hancock Award for business reporting. Lynn was also a Knight Medical School Fellow at the University of Michigan.

View all post by Lynn Eisler Visit author's website

Write Your Comment